PTHL vs IVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 02, 2026

PTHL

36.7
AI Score
VS
It's a Tie!

IVF

36.7
AI Score

Investment Advisor Scores

PTHL

37score
Recommendation
SELL

IVF

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric PTHL IVF Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -67.9% 16.7% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.7/100 36.7/100 Tie
Profit Margin 0.0% -70.2% PTHL
Beta 1.00 1.00 Tie
AI Recommendation SELL SELL Tie

Relative Price Performance (Last 90 Days)

PTHL 1M: +72.4% · 3M: +32.7% IVF 1M: -5.3% · 3M: -38.1%

Current Technical Phase

PTHL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 80

RSI (14): 80.3 · Price: $0.90

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 44

RSI (14): 43.7 · Price: $0.99

Fundamentals Snapshot

Metric PTHL IVF
Market Cap
Forward P/E 0.0 -0.1
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.7% 0.2%
Gross Margin 0.8% 0.4%
Operating Margin -30.8% -0.6%
EPS -0.17 357.88
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PTHL and IVF are evenly matched. This is a close call that depends on your specific investment goals.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.